The 10th annual Oncology Update will be held in 2024.
This virtual study day is for doctors and nurses, general practitioners, and pharmacists caring for people with cancer. Over the last 3 years, 144 people have attended.
Attend in person and further support your learning by reviewing the recordings and PowerPoint slides. Cannot attend on the day? Register and watch the recordings supported by access to a PDF of the slides. Delegates feedback that it is very useful to be able to pause the recordings, look up references and reflect on learning. It supports you to collate learning to share with your team. (See further 2023 feedback below)
We look forward to welcoming you to this exciting and informative day.
CPD: 5 credits 149615
Dr Mary Miller and Dr Matt Carey (Chairs)
Feedback in 2023 - thank you!
"Extremely interesting. So much change - really helpful. Should be mandatory for palliative care doctors!"
"Excellent range of speakers"
"Excellent oncology update today. Great resources available with references and guidelines"
"I love this Zoom format and will be back for more next year!"
Location: Virtual
Educational Credits: 5 Credits (Ref: 149615)
+ Venue
Virtual educational event
+ Speakers
Chairs: Dr Matt Carey & Dr Mary Miller
Confirmed speakers:
1. Genitourinary cancers: Dr Joao Barata, Consultant Oncologist, Oxford University Hospitals
2. Cancer Unknown Primary origin: Dr Elizabeth Smyth, Consultant Oncologist, Oxford University Hospitals
3. Haematological malignancies, stem cell transplants and CAR T-cell therapy. Dr Jennifer Vidrine, Consultant palliative medicine, Northern Centre for cancer care, Newcastle upon Tyne,
4. Advances in Immunotherapies & Targeted therapies - treatments and toxicities Dr Anna Olsson-Brown, Consultant Clinical Oncologist at the Royal Sussex County Hospital
Programme development in progress for 2024 - we want the 10th anniversary to be a special event.
+ Course Programmes
(timings TBC)
08.50 welcome
09.00 Advances in Immunotherapies & Targeted therapies - treatments and toxicities
10.00 Break
10.10 Genito-urinary cancers
11.10 Break
11.30 Cancer of Unknown Primary Origin
12.30 Haematological malignancies, stem cell transplants and CAR T-cell therapy
13.30 Break
13.40 Evidence update
14.25 Q&A
14.40 Close
+ Course Aims
Following the study day participants will:
- Have gained a deeper understanding of the current management of the tumour sites considered
- Be able to use the knowledge gained to help with the management of patients
- Be able to use new knowledge to aid in prognostication
- Have had an opportunity to ask questions and engage with the speakers to enable the translation of knowledge into practice
